Last checked at 6 Oct 2010 15:56
|
| ||||
| TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi | ||||
|
|
| |||
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: | Deltex Medical
| |||
| 2 Reason for the notification (please tick the appropriate box or boxes): | ||||
| An acquisition or disposal of voting rights | Yes | |||
| An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | No | |||
| An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | No | |||
| An event changing the breakdown of voting rights | No | |||
| Other (please specify): |
| No | ||
| 3. Full name of person(s) subject to the notification obligation: | Gartmore Investment Limited | |||
| 4. Full name of shareholder(s) (if different from 3.): | See attached schedule | |||
| 5. Date of the transaction and date on which the threshold is crossed or reached: | 1st October 2010 | |||
| 6. Date on which issuer notified: | 4th October 2010 | |||
| 7. Threshold(s) that is/are crossed or reached: | 11% | |||
| 8. Notified details: | ||||||||||||||||
| A: Voting rights attached to shares | ||||||||||||||||
| Class/type of shares if possible using the ISIN CODE | Situation previous to the triggering transaction | Resulting situation after the triggering transaction | ||||||||||||||
| Number of Shares | Number of Voting Rights | Number of shares | Number of voting rights | % of voting rights | ||||||||||||
| Direct | Direct | Indirect | Direct | Indirect | ||||||||||||
| GB0059337583 | 14,003,111
| 14,003,111
| 14,278,111
|
| 14,278,111 |
| 10.960% | |||||||||
|
| ||||||||||||||||
|
| ||||||||||||||||
| B: Qualifying Financial Instruments | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument | Expiration date | Exercise/ Conversion Period | Number of voting rights that may be acquired if the instrument is exercised/ converted. | % of voting rights | ||||||||||||
| - | - | - | - | - | ||||||||||||
|
| ||||||||||||||||
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument | Exercise price | Expiration date | Exercise/ Conversion period | Number of voting rights instrument refers to
| % of voting rights
| |||||||||||
| - | - | - | - |
- | Nominal | Delta | ||||||||||
| - | - | |||||||||||||||
|
| ||||||||||||||||
| Total (A+B+C) | ||||||||||||||||
| Number of voting rights | Percentage of voting rights | |||||||||||||||
|
14,278,111
| 10.960% | |||||||||||||||
| 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: | ||
|
| ||
|
| ||
| Proxy Voting: | ||
| 10. Name of the proxy holder: |
| |
| 11. Number of voting rights proxy holder will cease to hold: |
| |
| 12. Date on which proxy holder will cease to hold voting rights: |
| |
|
| ||
| 13. Additional information: | All figures are based on the Company's issued share capital of 130,273,003 as provided by Exshare
E mail contact RDU@Gartmore.com | |
| 14. Contact name: | RDU | |
| 15. Contact telephone number: | 0207 782 2224 | |